Research has shown that Fas/FasL is beneficial in relieving liver fibrosis via accelerating autophagy, while autophagy inhibitor impairs Fas/FasL-modulated hepatocyte apoptosis (9). The gene discussed is FAS; the disease is Hepatic fibrosis.